This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Prescribing Information can be found at the bottom of the page.
Inactivated Vaccines are developed using a live pathogen that is inactivated or killed so that it can no longer replicate itself.1 This means that when the inactivated vaccine is given, the pathogen is strong enough to generate an immune response, but without causing disease.1
This makes this form of vaccine much more suitable than live vaccines for those people suffering with immunocompromised conditions.1
Because inactivated vaccines do not contain live pathogens, they may not be as effective at stimulating a strong or long-lasting immune response. This means that multiple doses of the vaccine may be necessary to build up sufficient immunity, and periodic booster vaccines may be needed to maintain immunity over time.2,3
Pfizer's Inactivated Vaccines
Pfizer currently offers two Inactivated Vaccines.
TicoVac® (Tick-Borne Encephalitis Vaccine (whole Virus inactivated)) for immunisation against Tick-Borne Encephalitis (TBE) in persons aged 16 years of age and older.4
TicoVac® Junior (Tick-Borne Encephalitis Vaccine (whole Virus inactivated)) for immunisation against Tick-Borne Encephalitis (TBE) in children aged from 1 years to 15 years.5
Click on the button to right to visit the TicoVac brand site.
Help your customers to feel confident about vaccination - access MedISA to order printed clinic support materials to your surgery, pharmacy or other healthcare centre.
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
2. Vaccines Europe. Types of vaccines. Last accessed April 2023.
3. GAVI. What are whole virus vaccines and how could they be used against COVID-19? Last access April 2023.
4. TicoVac (Tick-Borne Encephalitis Vaccine). Summary of Product Characteristics. https://medicines.org.uk/emc/product/1923/smpc. Last accessed April 2023.
5. TicoVac Junior (Tick-Borne Encephalitis Vaccine). Summary of Product Characteristics. https://medicines.org.uk/emc/product/1927/smpc. Last accessed April 2023.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024